Skip to main content

Table 1 Demographic and clinical characteristics of 174 renal transplant recipients with mucormycosis

From: Mucormycosis in renal transplant recipients: review of 174 reported cases

Feature All patients Proportion of patients who died
Mean age, y 45.9 (range 11–70)  
Gender
 Male 133(76%) 58/133 (43.6%)
 Female 41(24%) 16/41 (39.0%)
Underlying conditions
 No 30/174 (25.1%) 15/30 (50.0%)
 Diabetes 75/174 (43.1%) 25/75 (33.3%)
 Other conditionsa 19/174 (3.4%) 7/19 (36.8%)
 Not reported 50/174 (28.7%) 27/50 (54.0%)
Transplanted organs
 Kidney alone 162/174(93.1%) 71/162(43.8%)
 Kidney combined with other organs 12/174(6.9%) 9/12(75.0%)
Anti-allograft rejection therapy
 Yes 33/174(18.97%) 12/33(36.4%)
 No 16/174(9.1%) 7/16(43.8%)
 Not reported 125/174(71.8%) 55/125(44.0%)
Induction therapy
 Yes 33/174(19.0%) 12/33(36.4%)
 No 16/174(9.2%) 7/16(43.8%)
 Not reported 125/174(71.8%) 55/125(71.8%)
Reduce immunosuppressive drugs
 Yes 98(56.3%) 38/98(38.8%)
 No 6(3.4%) 2/6(33.3%)
 Not reported 70(40.2%) 34/70(48.6%)
Diagnostic methods
 Histopathology only 72/174(41.4%) 33/72(45.8%)
 Culture only 25/174(14.4%) 9/25(36.0%)
 Histopathology and culture 77/174(44.3%) 32/77(41.6%)
  1. aIncluding surgery, dental extraction, HIV infection, malignancy, trauma, and deferoxamine therapy